Ardelyx (ARDX) EPS (Diluted) Growth (3y) (2016 - 2026)
Ardelyx (ARDX) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | -5.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.75% |
| Dec 31, 2025 | -26.52% |
| Sep 30, 2025 | 69.32% |
| Jun 30, 2025 | 24.54% |
| Mar 31, 2025 | 7.00% |
| Dec 31, 2024 | 27.17% |
| Sep 30, 2024 | 79.84% |
| Jun 30, 2024 | 46.25% |
| Mar 31, 2024 | 30.65% |
| Dec 31, 2023 | 25.87% |
| Sep 30, 2023 | 28.94% |
| Jun 30, 2023 | 34.24% |
| Mar 31, 2023 | 19.91% |
| Dec 31, 2022 | 30.44% |
| Sep 30, 2022 | 41.13% |
| Jun 30, 2022 | 36.86% |
| Mar 31, 2022 | 34.27% |
| Dec 31, 2021 | 24.39% |
| Sep 30, 2021 | 15.62% |
| Jun 30, 2021 | 11.13% |